Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H9BrFN3 |
Molecular Weight | 258.09 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=CC(Br)=C1NC2=NCCN2
InChI
InChIKey=KDPNLRQZHDJRFU-UHFFFAOYSA-N
InChI=1S/C9H9BrFN3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)
Molecular Formula | C9H9BrFN3 |
Molecular Weight | 258.09 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: O77721 Gene ID: NA Gene Symbol: ADRA2B Target Organism: Equus caballus (Horse) |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | SEDIVET Approved UseFor use as a sedative and analgesic to facilitate handling, clinical examinations, clinical procedures, and minor surgical procedures in adult horses; and for use as a preanesthetic prior to the induction of general anesthesia in adult horses. Launch Date2004 |
PubMed
Title | Date | PubMed |
---|---|---|
Cardiovascular effects of romifidine in dogs. | 2001 Apr |
|
Effect of two anaesthetic regimens on airway nitric oxide production in horses. | 2001 Jan |
|
Comparison of detomidine and romifidine as premedicants before ketamine and halothane anesthesia in horses undergoing elective surgery. | 2001 Mar |
|
Effect of romifidine on gastrointestinal motility, assessed by transrectal ultrasonography. | 2001 Nov |
|
Cardiovascular effects of romifidine in the standing horse. | 2002 Apr |
|
Analgesic, sedative and haemodynamic effects of spinally administered romifidine in female goats. | 2002 Feb |
|
Cardiovascular effects of a high dose of romifidine in propofol-anesthetized cats. | 2002 Sep |
|
Effects of alpha-2 adrenoceptor agonists during recovery from isoflurane anaesthesia in horses. | 2003 Mar |
|
The echocardiographic effects of romifidine in dogs with and without prior or concurrent administration of glycopyrrolate. | 2003 Oct |
|
Effects of tiletamine/zolazepam-romifidine-atropine in ocelots (Leopardus pardalis). | 2004 Jul |
|
Comparison of morphine and butorphanol as pre-anaesthetic agents in combination with romifidine for field castration in ponies. | 2005 Jan |
|
Effect of romifidine on the nociceptive withdrawal reflex and temporal summation in conscious horses. | 2005 Nov |
|
Romifidine or medetomidine premedication before propofol-sevoflurane anaesthesia in dogs. | 2005 Oct |
|
Risk factors for colic in horses after general anaesthesia for MRI or nonabdominal surgery: absence of evidence of effect from perianaesthetic morphine. | 2006 Jul |
|
A2-agonists in sheep: a review. | 2006 Mar |
|
Comparison of romifidine and medetomidine pre-medication in propofol-isoflurane anaesthetised dogs. | 2006 Nov |
|
Cardiorespiratory effects of desflurane in dogs given romifidine or medetomidine before induction of anesthesia with propofol. | 2006 Oct |
|
The effects of detomidine, romifidine or acepromazine on echocardiographic measurements and cardiac function in normal horses. | 2007 Jan |
|
Epithelial expression of mRNA and protein for IL-6, IL-10 and TNF-alpha in endobronchial biopsies in horses with recurrent airway obstruction. | 2008 Feb 23 |
|
Comparison of ketamine and S(+)-ketamine, with romifidine and diazepam, for total intravenous anesthesia in horses. | 2008 Jan |
|
Sedative and cardiorespiratory effects of three doses of romifidine in comparison with medetomidine in five cats. | 2008 Jan 19 |
|
A comparison of recovery times and characteristics with sevoflurane and isoflurane anaesthesia in horses undergoing magnetic resonance imaging. | 2008 Sep |
|
Effect of sedation with detomidine and butorphanol on pulmonary gas exchange in the horse. | 2009 May 7 |
|
Alfaxalone in cyclodextrin for induction and maintenance of anaesthesia in ponies undergoing field castration. | 2009 Sep |
|
Human exposures to immobilising agents: results of an online survey. | 2010 Aug 28 |
|
Alpha-2 agonists as pain therapy in horses. | 2010 Dec |
|
Effects of adding butorphanol to a balanced anaesthesia protocol during arthroscopic surgery in horses. | 2010 Mar 13 |
Patents
Sample Use Guides
Sedative doses ranged between 30 and 100 mcg/kg; preanesthetic doses ranged between 40 and 100 mcg/kg.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9647475
Rat spinal cord preparations were treated with romifidine at concentrations from 1 to 1000 nM. The drug depressed both the high intensity and low intensity excitatory postsynaptic potential with EC50 value of 23.4 nM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:21:53 GMT 2023
by
admin
on
Fri Dec 15 16:21:53 GMT 2023
|
Record UNII |
876351L05K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 522.2076
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
||
|
NCI_THESAURUS |
C47794
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
||
|
WHO-VATC |
QN05CM93
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID40216103
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
876351L05K
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
65896-16-4
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
876351L05K
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
C076257
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
1091919
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | RxNorm | ||
|
ROMIFIDINE
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
m11985
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
71969
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
6148
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
C74389
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105424
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
100000084375
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
SUB10374MIG
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY | |||
|
DB11543
Created by
admin on Fri Dec 15 16:21:53 GMT 2023 , Edited by admin on Fri Dec 15 16:21:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
SHORT-ACTING
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |